DEPUY IRELAND - 3015516266

Manufacturer adverse-event records for DEPUY IRELAND - 3015516266 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2021–2026 · mid-book · quiet Death-code · balanced

Death-code intensity

DEPUY IRELAND - 3015516266 is quieter on Death-coded events

Death-coded event_type rows are 2 of 8,096 (0.02% · quiet tercile among 443 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for DEPUY IRELAND - 3015516266

The standout signal for DEPUY IRELAND - 3015516266 is Death-code intensity: 0.02% of 8,096 reports (quiet tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for DEPUY IRELAND - 3015516266. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 5,729 (70.8% of event_type total). Peak single-year volume reaches 2,959 reports across 6 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

8,096
Total Reports
2
Event-type Death
2,365
Injury Reports
20
Device Types

Event Types

Malfunction 5,729 (70.8%)
Injury 2,365 (29.2%)
Death 2 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

5,616 (70.5%)
Required Intervention 2,347 (29.4%)
R 2 (0.0%)
Hospitalization 2 (0.0%)
D 1 (0.0%)
Death 1 (0.0%)
Life Threatening 1 (0.0%)

Yearly Trend

21
2021: 78
22
2022: 400
23
2023: 1,583
24
2024: 2,479
25
2025: 2,959
26
2026: 597